GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Poly Medicure Ltd (NSE:POLYMED) » Definitions » Beneish M-Score

Poly Medicure (NSE:POLYMED) Beneish M-Score : -2.45 (As of May. 15, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Poly Medicure Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.45 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Poly Medicure's Beneish M-Score or its related term are showing as below:

NSE:POLYMED' s Beneish M-Score Range Over the Past 10 Years
Min: -2.78   Med: -2.38   Max: -0.17
Current: -2.45

During the past 13 years, the highest Beneish M-Score of Poly Medicure was -0.17. The lowest was -2.78. And the median was -2.38.


Poly Medicure Beneish M-Score Historical Data

The historical data trend for Poly Medicure's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poly Medicure Beneish M-Score Chart

Poly Medicure Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.52 -2.65 -2.14 -2.17 -2.45

Poly Medicure Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -2.45 - - -

Competitive Comparison of Poly Medicure's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Poly Medicure's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Poly Medicure's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Poly Medicure's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Poly Medicure's Beneish M-Score falls into.



Poly Medicure Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Poly Medicure for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9321+0.528 * 0.9758+0.404 * 0.8084+0.892 * 1.2092+0.115 * 1.2791
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.977+4.679 * -0.007319-0.327 * 1.0276
=-2.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar23) TTM:Last Year (Mar22) TTM:
Total Receivables was ₹2,427 Mil.
Revenue was ₹11,087 Mil.
Gross Profit was ₹5,993 Mil.
Total Current Assets was ₹8,070 Mil.
Total Assets was ₹15,772 Mil.
Property, Plant and Equipment(Net PPE) was ₹6,624 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹572 Mil.
Selling, General, & Admin. Expense(SGA) was ₹381 Mil.
Total Current Liabilities was ₹2,933 Mil.
Long-Term Debt & Capital Lease Obligation was ₹189 Mil.
Net Income was ₹1,793 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹1,908 Mil.
Total Receivables was ₹2,153 Mil.
Revenue was ₹9,169 Mil.
Gross Profit was ₹4,837 Mil.
Total Current Assets was ₹7,834 Mil.
Total Assets was ₹13,768 Mil.
Property, Plant and Equipment(Net PPE) was ₹4,770 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹540 Mil.
Selling, General, & Admin. Expense(SGA) was ₹322 Mil.
Total Current Liabilities was ₹2,267 Mil.
Long-Term Debt & Capital Lease Obligation was ₹385 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2426.941 / 11086.582) / (2153.413 / 9168.879)
=0.218908 / 0.234861
=0.9321

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(4836.624 / 9168.879) / (5993.367 / 11086.582)
=0.527504 / 0.540596
=0.9758

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (8070.061 + 6623.781) / 15772.092) / (1 - (7834.366 + 4769.695) / 13768.347)
=0.068364 / 0.084563
=0.8084

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=11086.582 / 9168.879
=1.2092

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(539.522 / (539.522 + 4769.695)) / (571.668 / (571.668 + 6623.781))
=0.10162 / 0.079449
=1.2791

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(380.851 / 11086.582) / (322.396 / 9168.879)
=0.034352 / 0.035162
=0.977

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((188.505 + 2933.026) / 15772.092) / ((385.068 + 2266.783) / 13768.347)
=0.197915 / 0.192605
=1.0276

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1792.825 - 0 - 1908.262) / 15772.092
=-0.007319

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Poly Medicure has a M-score of -2.45 suggests that the company is unlikely to be a manipulator.


Poly Medicure Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Poly Medicure's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Poly Medicure (NSE:POLYMED) Business Description

Traded in Other Exchanges
Address
Okhla Industrial Estate, 232-B, 3rd Floor, Phase III, New Delhi, IND, 110020
Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.

Poly Medicure (NSE:POLYMED) Headlines

No Headlines